| DISA-LIFE-SCIENCES |
DISA-LIFE-SCIENCES |
92%
|
The Group has historical reliance on two parties for sales into South Africa: there is reliance on DISA Life Sciences as a customer |
| DISA-MEDINOTEC-PROPRIETY-LIMITED |
DISA-MEDINOTEC-PROPRIETY-LIMITED |
85%
|
ive August 1, 2025. This tariff was introduced unilaterally and is reportedly based on concerns over a perceived trade imbalance between the two nations. While the South African government has contes… |
| MINOAN-MEDICAL-PROPRIETARY |
MINOAN-MEDICAL-PROPRIETARY |
80%
|
for exports out of South Africa there was historical reliance on Minoan Medical Proprietary |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from MDNC graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from MDNC graph: Reciprocal relationship from JNJ grap… |
| JNJ |
Johnson & Johnson |
72%
|
rangements, such as gainsharing, where a hospital agrees with physicians to share any realized cost savings resulting from changes in practice patterns such as device standardization. This has create… |
| ALTHOUGH-MEDINOTEC-GROUP |
ALTHOUGH-MEDINOTEC-GROUP |
62%
|
s NC Catheter: Application for FDA 510(k) clearance in progress with external consultants. Final submission pending. CE certification has been obtained. Lamprey Suction Dissector: The progress of thi… |
| CAPITAL-THE-MEDINOTEC-GROUP |
CAPITAL-THE-MEDINOTEC-GROUP |
62%
|
ec Group of Companies insurance program may not be adequate to cover future losses. • The Medinotec Group of Companies future growth is dependent upon the development of new products and line extensi… |
| CONSOLIDATED-MEDINOTEC-GROUP |
CONSOLIDATED-MEDINOTEC-GROUP |
62%
|
e and debt service obligations could adversely affect the business. As of February 29, 2024, the consolidated Medinotec Group of Companies had approximately $827,454 of current liability obligations … |
| DISA-LIFE-SCIENCES-PROPRIETARY-LIMITED |
DISA-LIFE-SCIENCES-PROPRIETARY-LIMITED |
62%
|
the US. The Group has historical reliance on two related parties for sales into South Africa: there is reliance on DISA Life Sciences Proprietary Limited (“Disa Life Sciences”) as a customer; and for… |
| DISA-MEDINOTEC-PROPRIETARY-LIMITED |
DISA-MEDINOTEC-PROPRIETARY-LIMITED |
62%
|
nd an accredited Quality Management System (“QMS”), which was established in accordance with the requirements of ISO13485, the European Union Medical Device Regulation 2017/745, the US FDA 21 CFR 820… |
| DISA-MEDINOTEC-PROPRIETARY-LIMITED-THE-MEDINOTEC |
DISA-MEDINOTEC-PROPRIETARY-LIMITED-THE-MEDINOTEC |
62%
|
e and debt service obligations could adversely affect the business. As of February 29, 2024, the consolidated Medinotec Group of Companies had approximately $827,454 of current liability obligations … |
| EMERGING-GROWTH-COMPANY |
EMERGING-GROWTH-COMPANY |
62%
|
ec Group of Companies insurance program may not be adequate to cover future losses. • The Medinotec Group of Companies future growth is dependent upon the development of new products and line extensi… |
| GOODS-THE-CONSOLIDATED-MEDINOTEC-GROUP |
GOODS-THE-CONSOLIDATED-MEDINOTEC-GROUP |
62%
|
Value Added Taxes) • Rates taxes and Levies are billed in addition to the Rent • DISA Medinotec pays its own utility bills to the local service providers We do not have any policies regarding investm… |
| INTELLECTUAL-PROPERTY-MEDINOTEC-GROUP |
INTELLECTUAL-PROPERTY-MEDINOTEC-GROUP |
62%
|
s NC Catheter: Application for FDA 510(k) clearance in progress with external consultants. Final submission pending. CE certification has been obtained. Lamprey Suction Dissector: The progress of thi… |
| MEDINOTEC-CAPITAL-PROPRIETARY-LIMITED |
MEDINOTEC-CAPITAL-PROPRIETARY-LIMITED |
62%
|
ive August 1, 2025. This tariff was introduced unilaterally and is reportedly based on concerns over a perceived trade imbalance between the two nations. While the South African government has contes… |
| MEDINOTEC-GROUP |
MEDINOTEC-GROUP |
62%
|
oncentration Sales between the Medinotec Group and DISA Life Sciences are expected to remain strong, driven by DISA’s well-established and extensive distribution network in South Africa. This partner… |
| MEDINOTEC-INC-MEDINOTEC-CAPITAL-PROPRIETARY-LIMI |
MEDINOTEC-INC-MEDINOTEC-CAPITAL-PROPRIETARY-LIMI |
62%
|
mprovements, and quality enhancement initiatives. In accordance with ASC 730, the Company expenses all R&D costs as incurred. This includes costs directly related to research activities, as well as e… |
| MINOAN-CAPITAL-PROPRIETARY-LIMITED |
MINOAN-CAPITAL-PROPRIETARY-LIMITED |
62%
|
mprovements, and quality enhancement initiatives. In accordance with ASC 730, the Company expenses all R&D costs as incurred. This includes costs directly related to research activities, as well as e… |
| MINOAN-MEDICAL-PROPRIETARY-LIMITED |
MINOAN-MEDICAL-PROPRIETARY-LIMITED |
62%
|
cipating in both regional and international industry meetings and other trade associations and managing advertising efforts in trade journals. § Transportation Warehouse and Logistics team: The team … |
| OPERATING-EXPENSES-THE-CONSOLIDATED-MEDINOTEC-GR |
OPERATING-EXPENSES-THE-CONSOLIDATED-MEDINOTEC-GR |
62%
|
Value Added Taxes) • Rates taxes and Levies are billed in addition to the Rent • DISA Medinotec pays its own utility bills to the local service providers We do not have any policies regarding investm… |
| PRIMARY-CUSTOMERS-MEDINOTEC-GROUP |
PRIMARY-CUSTOMERS-MEDINOTEC-GROUP |
62%
|
e paid under such insurance policies in connection with a particular event. Primary Customers Medinotec Group of Companies primary customers include hospitals, clinics, third-party healthcare provide… |
| PRODUCT-RANGE-DISA-MEDINOTEC-PROPRIETARY-LIMITED |
PRODUCT-RANGE-DISA-MEDINOTEC-PROPRIETARY-LIMITED |
62%
|
on: We are dedicated to continuing to develop patentable products and offerings through R&D. § Experienced management team: The members of the Company’s management team bring considerable experience … |
| RENT-DISA-MEDINOTEC-PROPRIETY-LIMITED |
RENT-DISA-MEDINOTEC-PROPRIETY-LIMITED |
62%
|
tec Inc and Kingstyle investments. n/a Stavros G. Vizirgianakis Non-Executive director of the Medinotec Group of companies Brother of Gregory Vizirgianakis Transactions relating to mutual entities di… |
| SOUTH-AFRICA-THE-GROUP |
SOUTH-AFRICA-THE-GROUP |
62%
|
the US. The Group has historical reliance on two related parties for sales into South Africa: there is reliance on DISA Life Sciences Proprietary Limited (“Disa Life Sciences”) as a customer; and for… |
| SOUTH-AFRICA-THE-MEDINOTEC-INC-GROUP |
SOUTH-AFRICA-THE-MEDINOTEC-INC-GROUP |
62%
|
distribution arm of DISA Life Sciences within South Africa. The Medinotec Inc. Group’s expectation is to reduce reliance on the South African markets for customers and accounts as the Group endeavors… |
| STATES-GENERALLY-ACCEPTED-ACCOUNTING-PRINCIPLES- |
STATES-GENERALLY-ACCEPTED-ACCOUNTING-PRINCIPLES- |
62%
|
ive August 1, 2025. This tariff was introduced unilaterally and is reportedly based on concerns over a perceived trade imbalance between the two nations. While the South African government has contes… |
| USA-THE-MEDINOTEC-GROUP |
USA-THE-MEDINOTEC-GROUP |
62%
|
on: We are dedicated to continuing to develop patentable products and offerings through R&D. § Experienced management team: The members of the Company’s management team bring considerable experience … |
| US-THE-GROUP |
US-THE-GROUP |
62%
|
the US. The Group has historical reliance on two related parties for sales into South Africa: there is reliance on DISA Life Sciences Proprietary Limited (“Disa Life Sciences”) as a customer; and for… |
| YEARS-ENDED-THE-MEDINOTEC-GROUP |
YEARS-ENDED-THE-MEDINOTEC-GROUP |
62%
|
nd an accredited Quality Management System (“QMS”), which was established in accordance with the requirements of ISO13485, the European Union Medical Device Regulation 2017/745, the US FDA 21 CFR 820… |
